Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy

Sonia Jiménez-Vázquez, Anna Berthel, Christos Patsis, Mara Mitstorfer, Melanie Grimm, Luise Butthof, Lena Wendler-Link, Lio Böse, Hendrik Wiethoff, Ilse Hofmann, Kai Breuhahn, Thomas Longerich, Matthias M. Gaida, Peter Schirmacher, Judith Feucht, Meggy Suarez-Carmona, Patrick Schmidt, Fee Klupp, Martin Schneider, Markus Wallwiener, Dirk Jaeger, Niels Halama, Marco Breinig, Darjus F. Tschaharganeh

Open source

DOI: 10.1038/s41467-026-77465-5
Published: 2026-09-10
Container: Nature Communications
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-77465-5,
  title = {Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy},
  author = {Sonia Jiménez-Vázquez and Anna Berthel and Christos Patsis and Mara Mitstorfer and Melanie Grimm and Luise Butthof and Lena Wendler-Link and Lio Böse and Hendrik Wiethoff and Ilse Hofmann and Kai Breuhahn and Thomas Longerich and Matthias M. Gaida and Peter Schirmacher and Judith Feucht and Meggy Suarez-Carmona and Patrick Schmidt and Fee Klupp and Martin Schneider and Markus Wallwiener and Dirk Jaeger and Niels Halama and Marco Breinig and Darjus F. Tschaharganeh},
  year = {2026},
  journal = {Nature Communications},
  doi = {10.1038/s41467-026-77465-5},
  url = {https://doi.org/10.1038/s41467-026-77465-5}
}

RIS

TY  - JOUR
TI  - Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy
AU  - Sonia Jiménez-Vázquez
AU  - Anna Berthel
AU  - Christos Patsis
AU  - Mara Mitstorfer
AU  - Melanie Grimm
AU  - Luise Butthof
AU  - Lena Wendler-Link
AU  - Lio Böse
AU  - Hendrik Wiethoff
AU  - Ilse Hofmann
AU  - Kai Breuhahn
AU  - Thomas Longerich
AU  - Matthias M. Gaida
AU  - Peter Schirmacher
AU  - Judith Feucht
AU  - Meggy Suarez-Carmona
AU  - Patrick Schmidt
AU  - Fee Klupp
AU  - Martin Schneider
AU  - Markus Wallwiener
AU  - Dirk Jaeger
AU  - Niels Halama
AU  - Marco Breinig
AU  - Darjus F. Tschaharganeh
PY  - 2026
JO  - Nature Communications
DO  - 10.1038/s41467-026-77465-5
UR  - https://doi.org/10.1038/s41467-026-77465-5
ER  -

APA

Jiménez-Vázquez, S., Berthel, A., Patsis, C., Mitstorfer, M., Grimm, M., Butthof, L., Wendler-Link, L., Böse, L., Wiethoff, H., Hofmann, I., Breuhahn, K., Longerich, T., Gaida, M. M., Schirmacher, P., Feucht, J., Suarez-Carmona, M., Schmidt, P., Klupp, F., Schneider, M., Wallwiener, M., Jaeger, D., Halama, N., Breinig, M., & Tschaharganeh, D. F. (2026). Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy. Nature Communications. https://doi.org/10.1038/s41467-026-77465-5

Source records

crossref · retrieved 2026-09-26T03:55:51.435Z